881535
Regeneron Pharmaceuticals, Inc. · LS:881535
867.80 EUR46.00 +5.60%
Regeneron Pharmaceuticals, Inc. (LS:881535) last traded at 867.80 EUR, up 5.60% on the day. Over the past year the stock is up 54.08%. Its 52-week range is 513.10 to 867.80. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open828.00
Day range828.00 – 867.80
52-week range513.10 – 867.80
Volume29
Average volume (10 days)25
Market cap (USD)95.51 B
P/E21.70
EPS (TTM) (USD)45.30
Dividend yield0.40%
Beta (1 year)0.0814
Revenue (TTM) (USD)16.90 B
Employees15.41 K
Performance
+20.21%1 week
+33.53%1 month
+31.90%3 months
+45.38%6 months
+30.97%Year to date
+54.08%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Leerink Partners maintains Regeneron Pharmaceuticals at Market Perform, raises price target to $997 from $835TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $812.00/Share From $756.00 by BernsteinDow Jones Newswires · 02 Nov 2026
- Bernstein maintains Regeneron Pharmaceuticals at Market Perform, raises price target to $812 from $756TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $855.00/Share From $779.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains Regeneron Pharmaceuticals at Equal-Weight, raises price target to $855 from $779TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $913.00/Share From $810.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $982.00/Share From $780.00 by Truist SecuritiesDow Jones Newswires · 02 Nov 2026
- Truist Securities maintains Regeneron Pharmaceuticals at Buy, raises price target to $982 from $780TradingView · 02 Nov 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.